Cargando…
Tolérance de l’évérolimus en pratique clinique: étude retrospective
Everolimus is a mTOR inhibitor which demonstrates clinical activity in several solid tumors, especially in kidney cancer after first line TKI anti VEGF treatment and in breast cancer in association with exemesthane after failure of aroamatase inhibitors. The purpose of this study was to analyze in c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The African Field Epidemiology Network
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388605/ https://www.ncbi.nlm.nih.gov/pubmed/32774603 http://dx.doi.org/10.11604/pamj.2020.36.26.16580 |